LENSAR, Inc.
LNSR · XNASCIK 1320350fmd_0312EZ5YV17FGJQNF937EK0W6ZManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard
Coverage: Jan 01, 2019 to Sep 30, 2026, 31 periods
| Line item | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Rental revenue | 4 | 4 | 5 | 6 | 6 | 8 | 7 |
| Total revenues | 31 | 26 | 34 | 35 | 42 | 53 | 58 |
| Cost of revenue | 17 | 12 | 17 | 15 | 21 | 28 | 31 |
| Gross profit | 13 | 14 | 18 | 20 | 21 | 26 | 27 |
| Provision for credit losses | – | (0) | 0 | 0 | 0 | (0) | (0) |
| Research and development | 8 | 8 | 12 | 12 | 6 | 5 | 6 |
| Selling, general and administrative | 17 | 24 | 24 | 27 | 26 | 26 | 45 |
| Operating income | (13) | (19) | (20) | (20) | (12) | (11) | (25) |
| Interest expense | 2 | 1 | – | – | – | – | – |
| Other non-operating income (expense) | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
| Income before taxes | (15) | (20) | (20) | (20) | (14) | (31) | (34) |
| Net income | (15) | (20) | (20) | (20) | (14) | (31) | (34) |
| Net income to common shareholders | (15) | (20) | (20) | (20) | (14) | (31) | (34) |